A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

NCT01362296 ·Status: COMPLETED ·Phase: PHASE2

Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

NCT00043823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer

NCT01297491 ·Status: COMPLETED ·Phase: PHASE2

VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer

NCT05374538 ·Status: TERMINATED ·Phase: PHASE1

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

NCT06162221 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Sotorasib in KRAS G12C Mutated, Resectable, Stage Ib-IIIA NSCLC

NCT05400577 ·Status: WITHDRAWN ·Phase: PHASE2

Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

NCT00359450 ·Status: TERMINATED ·Phase: PHASE2

Tarlox and Sotorasib in Patients With KRAS G12C Mutations

NCT05313009 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of Sotorasib in People With Non-Small Cell Lung Cancer

NCT06582771 ·Status: RECRUITING ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215 ·Status: RECRUITING ·Phase: PHASE3

A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients

NCT06186076 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of TAS3351 in NSCLC Patients With EGFRmt

NCT05765734 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00651508 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

NCT05789082 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

NCT05435248 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

NCT06345729 ·Status: RECRUITING ·Phase: PHASE3

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

NCT07431827 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

NCT07541170 ·Status: RECRUITING ·Phase: PHASE3

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

NCT00099879 ·Status: TERMINATED ·Phase: PHASE2

A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens

NCT00294736 ·Status: COMPLETED ·Phase: PHASE1

Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)

NCT01027676 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer

NCT03774732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

NCT04216316 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer

NCT05435274 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

NCT07566052 ·Status: RECRUITING ·Phase: PHASE3